In terms of market performance, Moderna Inc had a somewhat inconsistent run in. The highest value for the stock in the past year was $170.47 on 05/24/24, while the lowest value was $35.80 on 11/15/24.
52-week price history of MRNA Stock
Analyzing the 52-week price history of a stock, including its high and low prices, can provide valuable insight into its current status and potential future performance. Moderna Inc’s current trading price is -75.39% away from its 52-week high, while its distance from the 52-week low is 17.18%. The stock’s price range for this period has remained between $35.80 and $170.47. The Healthcare sector company’s shares managed to surpass a trading volume of around 5.79 million for the day, which was noticeably lower compared to the shares’ average daily volume of 6.53 million over the last three months.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Financial Performance and Market Capitalization
Moderna Inc (MRNA) has experienced a quarterly decline of -48.63% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 16.14B and boasts a workforce of 5600 employees.
Moving average and trading volume data
Based on Barchart.com data, the company’s moving average over the 100-day period was 75.42, with a change in price of -74.67. Similarly, Moderna Inc recorded 5,589,375 in trading volume during the last 100 days, posting a change of -64.40%.
MRNA Debt-to-equity ratio analysis
The debt-to-equity (D/E) ratio is a valuable metric that offers insight into a company’s financial health and standing in the market. This ratio is calculated by dividing a company’s current total liabilities by its shareholders’ equity. The D/E ratio illustrates the extent of debt a company is utilizing to support its assets in relation to the value of its shareholders’ equity. At the time of writing, the total D/E ratio for MRNA stands at 0.11. Similarly, the long-term debt-to-equity ratio is also 0.11.
MRNA Stock Stochastic Average
As of today, the raw stochastic average of Moderna Inc over the past 50 days is 13.85%. This is a decrease compared to the raw stochastic average of the last 20 days, which was recorded at 25.03%. Additionally, the Stochastic %K and %D values for the company were 13.81% and 10.40%, respectively, over the past 20 days.
MRNA Stock Price Performance Analysis
A mixed performance in the stock price over the year has left investors with either an optimistic or pessimistic outlook, depending on their point of view. The index has shown a price loss of -57.82% this year. Over the last six months, there has been a stronger performance of -74.82%. The price of MRNA leaped by -20.55% during the last 30 days period. For the last 5-days stocks have improved 13.84%.
